OrbusNeich Medical (06929) Releases Monthly Return for October 2025

Bulletin Express

Nov 03

OrbusNeich Medical Group Holdings Limited (stock code: 06929) published its monthly return for the period ended 31 October 2025. According to the announcement, the authorized share capital remained at 1,200,000,000 ordinary shares with a par value of USD 0.0005, totaling USD 600,000. The number of issued shares likewise stayed at 827,968,337, with no treasury shares reported.

Under the Pre-IPO Share Option Scheme, 24,000 share options lapsed, reducing the total outstanding options to 7,748,500 by the end of the month. The Post-IPO Share Option Scheme also saw a lapse of 75,000 share options, bringing the total outstanding options for that scheme to 4,494,500. There were no new shares issued from either scheme, and no treasury shares were transferred during the reporting period. The company did not raise funds through the exercise of share options in October.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/news/1185744801"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1185744801\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1185744801?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-11-03 13:49","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1185744801","market":"hk","top_or_hot":-1,"title":"OrbusNeich Medical (06929) Releases Monthly Return for October 2025","media":"Bulletin Express","content":"<p>OrbusNeich Medical Group Holdings Limited (stock code: 06929) published its monthly return for the period ended 31 October 2025. According to the announcement, the authorized share capital remained at 1,200,000,000 ordinary shares with a par value of USD 0.0005, totaling USD 600,000. The number of issued shares likewise stayed at 827,968,337, with no treasury shares reported.</p>\n<p>Under the Pre-IPO Share Option Scheme, 24,000 share options lapsed, reducing the total outstanding options to 7,748,500 by the end of the month. The Post-IPO Share Option Scheme also saw a lapse of 75,000 share options, bringing the total outstanding options for that scheme to 4,494,500. There were no new shares issued from either scheme, and no treasury shares were transferred during the reporting period. The company did not raise funds through the exercise of share options in October.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>OrbusNeich Medical (06929) Releases Monthly Return for October 2025</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nOrbusNeich Medical (06929) Releases Monthly Return for October 2025\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2025-11-03 13:49</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>OrbusNeich Medical Group Holdings Limited (stock code: 06929) published its monthly return for the period ended 31 October 2025. According to the announcement, the authorized share capital remained at 1,200,000,000 ordinary shares with a par value of USD 0.0005, totaling USD 600,000. The number of issued shares likewise stayed at 827,968,337, with no treasury shares reported.</p>\n<p>Under the Pre-IPO Share Option Scheme, 24,000 share options lapsed, reducing the total outstanding options to 7,748,500 by the end of the month. The Post-IPO Share Option Scheme also saw a lapse of 75,000 share options, bringing the total outstanding options for that scheme to 4,494,500. There were no new shares issued from either scheme, and no treasury shares were transferred during the reporting period. The company did not raise funds through the exercise of share options in October.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"06929","symbol_name":"业聚医疗","start_time":0,"source_url":"","article_id":"1185744801","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1185744801","pubTimestamp":1762148952,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"OrbusNeich Medical Group Holdings Limited (stock code: 06929) published its monthly return for the period ended 31 October 2025. According to the announcement, the authorized share capital remained...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"06929":"业聚医疗"},"translate_title":"OrbusNeich Medical(06929)发布2025年10月月报表","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"06929":1},"content_text":"OrbusNeich Medical Group Holdings Limited (stock code: 06929) published its monthly return for the period ended 31 October 2025. According to the announcement, the authorized share capital remained at 1,200,000,000 ordinary shares with a par value of USD 0.0005, totaling USD 600,000. The number of issued shares likewise stayed at 827,968,337, with no treasury shares reported.\nUnder the Pre-IPO Share Option Scheme, 24,000 share options lapsed, reducing the total outstanding options to 7,748,500 by the end of the month. The Post-IPO Share Option Scheme also saw a lapse of 75,000 share options, bringing the total outstanding options for that scheme to 4,494,500. There were no new shares issued from either scheme, and no treasury shares were transferred during the reporting period. The company did not raise funds through the exercise of share options in October.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"dataReport,SGX","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"}}}